Frank Adell

Form D signer

Frank Adell

Chief Executive Officer at Cognos Therapeutics

Form D signer

Capital raised by Cognos Therapeutics

$250K+$250K latest round

1 Form D filing · first filed May 2026 · Inglewood, CA

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: —

Career

1 company on file

Cognos TherapeuticsBiotech · Inglewood, CAsince May 2026

Chief Executive Officer

Signatory on Cognos Therapeutics's Form D filings · $250K raised across 1

Company filings

via EDGAR · Form D for Cognos Therapeutics1

DateCompanyFormAmountRole on filing

May 21, 2026Cognos TherapeuticsForm D+$250KChief Executive Officer

Form DMay 21, 2026 · Cognos Therapeutics+$250Kas Chief Executive Officer

Overview

Last filing May 21, 2026

Frank Adell is on file as Chief Executive Officer at Cognos Therapeutics in Inglewood, CA. Cognos Therapeutics has 1 Form D filing on record, $250K raised in total. Frank Adell appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Cognos Therapeutics · 1

Eli GangDirector

Products

Cognos Therapeutics · 1

SINNAIS implantable smart pumpImplantable medical device

An AI-driven implantable pump that infuses therapeutics directly into the brain's ventricles along the cerebrospinal fluid pathway, while sampling and analyzing CSF in real time and reporting wirelessly to the treating physician.